TABLE 5.
Variable | β | SE | Wald | OR (95% CI) | P |
1 y N-MID | −0.108 | 0.108 | 0.989 | 0.898 (0.726-1.110) | 0.320 |
N-NID change | −0.064 | 0.106 | 0.360 | 0.938 (0.762-1.156) | 0.548 |
1 y P1NP | −0.053 | 0.041 | 1.613 | 0.949 (0.875-1.029) | 0.204 |
P1NP change | −0.002 | 0.035 | 0.004 | 0.998 (0.933-1.068) | 0.952 |
1 y β-CTX | −2.662 | 3.779 | 0.496 | 0.070 (0.000-114.913) | 0.481 |
β-CTX change | −1.524 | 2.520 | 0.366 | 0.218 (0.002-30.394) | 0.545 |
Phosphorus change | −0.210 | 1.894 | 0.012 | 0.811 (0.020-33.181) | 0.912 |
Alcohol intake | −0.719 | 0.591 | 1.478 | 0.487 (0.153-1.553) | 0.224 |
Physical activity | 1.925 | 0.614 | 9.834 | 6.856 (2.058-22.839) | 0.002 |
Treatment | 1.632 | 0.609 | 7.185 | 5.114 (1.551-16.864) | 0.007 |
Data are presented as value, or value (95% CI). P value < 0.05 was considered to indicate a statistically significant difference (highlighted in bold).
BMD, bone mineral density; β, regression coefficient; β-CTX, β-C-terminal telopeptide of type I collagen; CI, confidence interval; LS, lumbar spine; N-NID, N-terminal middle segment osteocalcin; OR, odds ratio; P1NP, propeptide of type I procollagen; SE, standard error.